The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease

BACKGROUND: Strict glycaemic control in patients with type 2 diabetes has proven to have microvascular benefits while the effects on CVD and mortality are less clear, especially in high risk patients. Whether strict glycaemic control would reduce the risk of future CVD or mortality in patients with...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cardiovasc Diabetol
Glavni autori: Bots, Sophie H., van der Graaf, Yolanda, Nathoe, Hendrik M. W., de Borst, Gert Jan, Kappelle, Jaap L., Visseren, Frank L. J., Westerink, Jan
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Original Investigation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4950600/
https://ncbi.nlm.nih.gov/pubmed/27431507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-016-0418-1
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items